Select Period Type
Indie only
Top Ratings Podcasts
May 19, 2024
The Best Ratings Podcasts from millions of podcasts available on the Goodpods platform and ranked by listens, ratings, comments, subscriptions and shares.
Unfortunately, there are no rankings in this category at the moment. Please check back again later!
Check out these Ratings Podcasts
Screen Cares
New
None
Top 10 Best The Crump - Chicago's Relatively Underground Music Podcast Episodes
10 Episodes
0|
00Latest episode 12 years ago
Share
We only play stuff from independent and unsigned Chicago artists. Visit us at http://mycrump.blogspot.com or email us at [email protected] if you would like to get more information about putting your music on the show.
Top 10 Best Is This Show Overrated? Episodes
73 Episodes
|
Avg Length 63m
|
Latest episode 5 months ago
Share
Podcast by Rainbow Alley Productions
Top 10 Best 2 Dudes and a NES: A Nintendo Podcast Episodes
186 Episodes
|
Avg Length 77m
|
Latest episode 2 months ago
Share
We're 2 dudes and a NES. We record game by game podcasts about the Nintendo Entertainment System.
Join our hosts, Melissa, Dan, and Allaya as they sample a different coffee each week to decide if what is advertised on the label is marketing or snarketing. Looking for a new roast to try? Start here to find your new favorite roast or save your $$$!
Fixed Income in 15 (FI15) is a long form conversation between a senior investor, CEO or entrepreneur and S&P Global Ratings on topics that are important for the investment community. Created and hosted by Joe Cass, episodes typically cover markets and investment trends, alongside personal experiences, stories and anecdotes plus hobbies, sports and working life.
Perspectives
New
From equities and fixed income to commercial real estate, ESG and climate change, join us as we explore the issues global investors are talking about and uncover insights from industry experts that help keep it all in perspective.
Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&P Pharma Dose podcast from S&P Global Ratings discusses all things pharma from a credit perspective.